Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors
NCT04999826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105
Last updated 2025-12-30
Summary
This study gathers information to create a database to improve the ability to diagnose cancer, predict long term health of breast cancer patients, and help develop future treatment products. This study will provide a foundational platform for therapeutic development and intervention studies in the future and may for therapeutic development and intervention studies in the future, and may advance researchers understanding of the contribution gut bacteria to altered circulating estrogens in breast cancer survivors.
Conditions
- Anatomic Stage 0 Breast Cancer AJCC v8
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage IA Breast Cancer AJCC v8
- Anatomic Stage IB Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage IIA Breast Cancer AJCC v8
- Anatomic Stage IIB Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Anatomic Stage IIIA Breast Cancer AJCC v8
- Anatomic Stage IIIB Breast Cancer AJCC v8
- Anatomic Stage IIIC Breast Cancer AJCC v8
- Prognostic Stage 0 Breast Cancer AJCC v8
- Prognostic Stage I Breast Cancer AJCC v8
- Prognostic Stage IA Breast Cancer AJCC v8
- Prognostic Stage IB Breast Cancer AJCC v8
- Prognostic Stage II Breast Cancer AJCC v8
- Prognostic Stage IIA Breast Cancer AJCC v8
- Prognostic Stage IIB Breast Cancer AJCC v8
- Prognostic Stage III Breast Cancer AJCC v8
- Prognostic Stage IIIA Breast Cancer AJCC v8
- Prognostic Stage IIIB Breast Cancer AJCC v8
- Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo biospecimen collection
- OTHER
-
Quality-of-Life Assessment
Ancillary studies
- OTHER
-
Questionnaire Administration
Complete questionnaires
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Brent A. Bauer, M.D. · Mayo Clinic in Rochester
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-04-01
- Primary Completion
- 2022-12-30
- Completion
- 2022-12-30
Countries
- United States
Study Locations
More Related Trials
-
Breast Cancer Survivorship Biorepository
NCT05786664 ·Status: RECRUITING
-
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
NCT07207564 ·Status: RECRUITING
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Living Well With Advanced Breast Cancer
NCT07227038 ·Status: RECRUITING
-
A Multicenter Breast Cancer Biospecimen Registry
NCT02712645 ·Status: UNKNOWN
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
NCT00823654 ·Status: RECRUITING
-
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 ·Status: WITHDRAWN
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
NCT04022616 ·Status: RECRUITING
-
Liquid Biopsies and Imaging in Breast Cancer
NCT04223492 ·Status: COMPLETED ·Phase: NA
-
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
NCT05042687 ·Status: RECRUITING ·Phase: NA
-
Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging
NCT01027767 ·Status: COMPLETED
-
Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy
NCT02259218 ·Status: COMPLETED
-
Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy
NCT02335671 ·Status: COMPLETED ·Phase: NA
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
NCT00040222 ·Status: COMPLETED
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
3D Ultrasound Breast Imaging
NCT04692818 ·Status: RECRUITING ·Phase: NA
-
Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
NCT07331506 ·Status: RECRUITING
-
Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703 ·Status: COMPLETED
-
Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer
NCT06918262 ·Status: RECRUITING
-
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
NCT01286233 ·Status: UNKNOWN